Disruptions in liver function among cancer patients and patients treated with tyrosine kinase inhibiting drugs: Comparisons of two population-based databases
10.1155/2013/358285
Saved in:
Main Authors: | Landis, S.H, Nordstrom, B.L, Sansbury, L.B, Shantakumar, S, Laurent, S.A.S, Fraeman, K.H, Nelson, J.J |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/181816 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Evidence for disease control with erlotinib after gefitinib failure in typical gefitinib-sensitive Asian patients with non-small cell lung cancer
by: Wong, A.S., et al.
Published: (2014) -
Evidence-based treatment options for the management of skin toxicities associated with epidermal growth factor receptor inhibitors
by: Eng, H.T., et al.
Published: (2014) -
EXPLORING THE ROLE OF PHARMACOKINETIC ALTERATIONS IN TYROSINE KINASE INHIBITORS (TKIS)-ASSOCIATED TOXICITIES
by: TEO YI LING
Published: (2015) -
Functional genome-wide screening identifies targets and pathways sensitizing pancreatic cancer cells to dasatinib
by: Chien W., et al.
Published: (2020) -
Brain metastases in Asian HER2-positive breast cancer patients: Anti-HER2 treatments and their impact on survival
by: Yap, Y.S., et al.
Published: (2014)